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Abstract
Purpose: Although there is a declining trend in the global burden of leprosy, there are 15 countries in Asia and Africa
which account for 94% of the global total of the new-case detection rate. Here, we assess the impact of diﬀerent
intervention strategies aimed at leprosy eradication through targeting non-symptomatic and symptomatic individuals.
Methods: We develop a mathematical model of leprosy transmission and treatment amongst symptomatic and
non-symptomatic, in order to investigate the eﬀects of leprosy relapse cases, case ﬁnding of non-symptomatic
individuals and compliance to therapy of individuals administered with treatment. Comparison theory has been
qualitatively used to analyze the global stability of the disease-free equilibrium. With the aid of centre manifold theory,
the local stability of the endemic equilibrium has been investigated. Population-level eﬀects of increased case
ﬁndings and high treatment rate (guaranteed by compliance and completion of therapy via educational campaigns)
are evaluated through numerical simulations and presented in support of the analytical results.
Results: Comprehensive and qualitative mathematical analysis of the model reveals that, the disease-free equilibrium
is globally, asymptotically stable whenever the reproductive number is less than unity. Further, we have established
that the model has a locally, asymptotically stable endemic equilibrium when the reproductive number is greater, but
close to unity. Numerical simulation suggests that case ﬁnding of non-symptomatic leprosy carriers, greater that 40%
is necessary for reducing leprosy prevalence and maybe useful on attaining leprosy eradication.
Conclusions: At its best, the study suggests that high level of case ﬁnding targeting non-symptomatic and
symptomatic individuals, together with high level of compliance by individuals on treatment, may have a substantial
eﬀect on controlling leprosy relapses and possible may assist on attaining leprosy eradication.
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Background
Although documented for many years, leprosy currently
remains endemic in some developing parts of the world
[1]. Leprosy is curable, and treatment provided in the
early stages averts disability. According to oﬃcial reports
received from 121 countries and territories, the global
registered prevalence of leprosy at the beginning of 2009
stood at 213,036 cases, while the number of new cases
during 2008 was 30,055 cases and 31,037 cases in 2007
[2] for a disease which appeared to be vanishing in the
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seventeenth and eighteenth centuries [3]. In 1991, the
WorldHealthOrganization (WHO) and its member states
committed themselves to eliminate leprosy as a public
health problem by the year 2000 [4]. Elimination was
deﬁned as a prevalence of less than 1 case per 10,000
persons. At the end of the year 2000, the deadline of
the program, 597,232 leprosy cases were registered for
treatment, and 719,330 cases were newly detected in
the world [5]. Despite these tremendous eﬀorts by the
World Health Organization to eradicate leprosy, pockets
of high endemicity still remain in some developing coun-
tries around the subtropical and tropical zone where the
social and economic resources have not been suﬃcient to
support the living standards needed to limit the disease.
© 2012 Mushayabasa and Bhunu; licensee Springer. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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Here, we list the highest registered prevalences as of 2008:
Angola (1,184 cases), Brazil (39,914 cases), Democratic
Republic of Congo (6,114 cases), Ethiopia (4,187 cases),
India (134,184 cases), Madagascar (1,763 cases), Mozam-
bique (1,313 cases), Nepal (4,708 cases), Sudan (1,901
cases), Nigeria (4,899 cases), Sri-Lanka (1,979 cases) and
the United Republic of Tanzania (3,276 cases) [2].
Mathematical models have become invaluable manage-
ment tools for epidemiologists, both shedding light on the
mechanisms underlying the observed dynamics as well
as making quantitative predictions on the eﬀectiveness of
diﬀerent control measures. The literature and develop-
ment of mathematical epidemiology are well documented
and can be found in [6-8].
This study intends to investigate the eﬀects of early
therapy to latently infected individuals and the role of
non-compliance to leprosy dynamics. Adhering to a treat-
ment schedule and successfully completing it are crucial
to the control of any disease [5,9]. Poor adherence to
self-administration of treatment of a chronic disease is a
common behavioral problem, [9,10] including TB [11,12]
and leprosy [13].
The paper is structured as follows. The model is for-
mulated in the ‘Methods’ section and comprehensively
analyzed in the section ‘Analytical results’. Expected pop-
ulation eﬀects from improved public health practices
are investigated in the section ‘Results and discussion’
through numerical simulations of the model using a set
of plausible parameter values abound in literature. A brief
conclusion rounds up the paper.
Analytical results
In this section, we derive the equilibrium states, disease-
free (DFE) and endemic (EE), of system (11) and investi-
gate their stability using the reproductive number.
Disease-free equilibrium
Model system (11) has an evident DFE given by
E0 =
(






, 0, 0, 0, 0, 0
)
. (1)
The linear stability of E0 is governed by the basic repro-
duction number, which is deﬁned as the spectral radius of
the next generation matrix [14]. Following the next gener-
ation approach and the notation deﬁned therein [14], the
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Thus, the reproductive number is given by
RPM = β(A1−A2 )A3+A4 ,
where A1 > A2 ,
and
A1 = (1 − f )(θαP − αM)[ qP((1 − δ)σφ + 1γM)
−qM (δσφ + 1γP)] ,
A2 = 2[ κφqP + 3(δσφ + 1γP)]+θ(μ + αP + νP )
×[ κφqM + 3((1 − δ)σφ + 1γM))] ,
A3 = f [ 2αP (κφqP + 2(δσφ + 1γP))
+αM4(κφqM + 2((1 − δ)σφ + 1γM)] ,
A4 = 2(μ + φ + γP + γM)[ (1 − f )1q4αPqP
+4((1 − f )αMqM − 23)] ,
with
1 = μ + κ + σ , 2 = μ + αM + νM,
3 = μ + qP + qM, 4 = (μ + αP + νP ).
(4)
The threshold quantityRPM measures the average num-
ber of new secondary cases generated by a single infec-
tious individual in a population where the aforementioned
control measures are in place. Using Theorem 2 in [14],
the following result is established.
Lemma 1. The disease-free equilibrium E0 of system
(11) is locally, asymptotically stable if RPM < 1 and
unstable ifRPM > 1.
Global stability of the disease-free
We claim the following result.
Lemma 2. The disease-free equilibrium (E0) of model
system (11) is globally, asymptotically stable (GAS) if
RPM < 1 and unstable ifRPM > 1.
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Proof. The proof is based on using a comparison
theorem [15]. Note that the equations of the infected
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where F and V are as deﬁned earlier on Equations 2 and


















Using the fact that the eigenvalues of thematrix F−V all
have negative real parts, it follows that the linearized dif-
ferential inequality system (5) is stable wheneverRPM < 1.
Consequently, (E, ED , P, M, R) −→ (0, 0, 0, 0, 0) as t −→
∞. Thus, by comparison theorem [15], (E, ED , P, M, R)
−→(0, 0, 0, 0, 0) as t −→ ∞, and evaluating system (11)
at E =ED= P =M = 0 gives S −→ S0 forRPM < 1. Hence,
the DFE (E0) is GAS forRPM < 1.
Sensitivity analysis of RPM Due to the complexity
nature of the expressionwhich deﬁnesRPM , we shall apply
numerical simulations to investigate the impact of (a) dis-
ease relapse when both strains co-exist, (b) reduction in
treatment compliance and (c) role of leprosy case ﬁnd-
ings at latent stage. From Figure 1, trend line (a) shows
the eﬀects of disease relapse on the reproductive number
RPM , and series (b) shows the eﬀects of decreasing treat-
ment compliance level. Figure 1 suggests that an increase
in relapse rate and a decrease in treatment compliance
level will result in an increase inRPM , thus increasing lep-
rosy prevalence in the community, which is a negative
impact on the WHO campaign to eradicate leprosy epi-
demic. However, from series (c), we note that an increase
in the leprosy case ﬁndings at the latent stage may have a
positive impact on the leprosy eradication campaign since
the increase in the case ﬁnding level results in a marked
decrease ofRPM . Further analysis of Figure 1 suggests that
if q ≥ 0.05, thenRPM > 1.
Endemic equilibriumand stability analysis
Model system (11) has an endemic state given by E∗ =
(S∗, E∗, E∗D, P∗,M∗,R∗). In order to analyze the stability
of this equilibrium point (E∗), we make use of the cen-
tre manifold theory [16] as described in Theorem 4.1 of
Castillo-Chavez and Song [16]. To establish the local sta-
bility, we deﬁne S = x1 , E = x2 , ED = x3 , P = x4 ,M = x5 ,
R = x6 so that N =
∑6
i=1 xi . Using the vector nota-
tion X = (x1 , x2 , x3 , x4 , x5 , x6)T , model system (11) under
these conditions can be written in the form dXdt = F =
(f1 , f2 , f3 , f4 , f5 , f6)T , such that




x′2 = f2 =
β(x4+θx5 )x1∑6
i=1 xi
+ f αPx4 + f αMx5
−(γP + φ + γM + μ)x2 ,
x′3 = f3 = φx2 − (κ + σ + μ)x3 ,
x′4 = f4 = γPx2 + σδx3 + qpx6 − (αP + μ + νP)x4 ,
x′5 = f5 = γMx2 + σ(1 − δ)x3 + qMx6
−(αM + μ + νM)x5 ,
x′6 = f6 = κx3 + (1 − f )αPx4 + (1 − f )αMx5
−(qP + qM + μ)x6 .
(6)
We now evaluate the Jacobian J(E0) of system (6) at
the disease-free (E0) in order for us to ﬁnd the right and
Figure 1 Simulations showing the impact of disease relapse,
reduction in treatment compliance and leprosy case ﬁndings.
Simulation of model system (11) showing (curve a) disease relapse
when both strains co-exist, (curve b) reduction in treatment
compliance and (curve c) role of leprosy case ﬁndings at latent stage.
Parameter values used are as in Table 1, with either q, f or φ varying in
steps of 0.1.
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left eigenvalues, which are necessary for determining the
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From Equation 7, it follows that the reproductive num-
ber is given by
RPM = β(A1−A2 )A3+A4 ,
withA1 ,A2 ,A3 ,A4 as deﬁned in Equation 4.
(8)
If β is taken as the bifurcation parameter, solving for β =
β∗ whenRPM = 1, we obtain
β = β∗ = A3+A4A1−A2 . (9)
Thus, the linearized system of the transformed system (6)
with β = β∗ chosen as a bifurcation parameter has a
simple zero eigenvalue. Hence, it can be shown that the
Jacobian (Equation 7) at β = β∗ has a right and left
eigenvector given below.
Eigenvectors of J(E0) It can be shown that the Jaco-
bian J(E0) of system (6) at β = β∗ has a right eigenvec-
tor (corresponding to the zero eigenvalue) given by u =







, u2 > 0, u3 = φu2κ+σ+μ ,
u4 = γPu2+σδu3+qPu6μ+αP+νp ,
u4 = γMu2+σ(1−δ)u3+qMu6μ+αM+νM ,
u5 = κu3+(1−f )[αPu4+αMu5 ]μ+qp+qM .
Furthermore, the Jacobian J(E0) has a left eigenvec-
tor (associated with the zero eigenvalue) given by z =




z1 = 0, z2 > 0, z3 = σδz4+σ(1−δ)z5+κz6κ+μ+σ ,
z4 = (β
∗+f αP )z2+(1−f )αP z6
μ+αP+νP ,
z5 = (θβ
∗f αM+)z2+(1−f )αM z6
μ+αM+νM , z6 =
qp z4+qM z5
μ+qP+qM .
Computations of the bifurcation coeﬃcients a and b
It can be shown, after some algebraic manipulations
(involving the associated non-zero partial derivative of F
(at the DFE) to be used in the expression (for a) and (b)








∗μ(u2 + u3 + u4 + u5 + u6)(u4 + θu5)z2

< 0,
b = (u4 + θu4)z2 > 0. (10)
We summarise the result in Lemma 3 below.
Lemma 3. The endemic equilibrium (E∗) is locally,
asymptotically stable for RPM > 1, but close to 1, as
guaranteed by Theorem 4.1 [16].
Results and discussion
Population-level eﬀects
In order to illustrate the results of the foregoing analysis
in this study, we carry out detailed numerical simula-
tions using MATLAB ODE solver, ode 45 programming
language and parameter values summarized in Table 1.
Unfortunately, the scarcity of data on the transmission
dynamics of leprosy limits our ability to calibrate, but
nevertheless, we assume some of the parameters in the
realistic range for illustrating the dynamics. These parsi-
monious assumptions reﬂect the lack of information cur-
rently available on the transmission dynamics of the lep-
rosy epidemic. Since this theoretical study is seemingly the
ﬁrst of its kind, it should be seen as a template for future
research, especially in data collection in this section.
Figure 2a demonstrates the eﬀects of increasing leprosy
relapse cases over a period of 100 years. If there are leprosy
relapse cases, then the annual incidence of active leprosy
decreases sharply in the presence of case ﬁnding of non-
symptomatic carriers together with treatment of symp-
tomatic carriers. Simulations, suggest that increasing
relapse cases may result in increased leprosy prevalence.
Figure 2b clearly demonstrates the impact of diﬀerent
treatment compliance levels for leprosy patients on ther-
apy. We observe that a decrease in treatment compliance
level may increase leprosy prevalence in the community.
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Table 1 Model parameters and their interpretations
Parameter Symbol Value Source
Recruitment rate for humans  100,000 year−1 [17]
Natural mortality rate for humans μ 0.025 year−1 [17]
Disease-induced mortality rate νp, νM (0.2, 0.25) year−1 [18]
Eﬀective contact rate β , 0.30 (0.11 to 0.95) [18]
Enhancement factor θ 1.35 [18]
Relapse rate qP, qM (0.1, 0.06) year−1 [19]
Recovery rate αP,αM, κ (0.54, 0.57, 0.65) year−1 [18]
Case ﬁnding rate for latently infected individuals φ variable [18]
Rate of progression from latent to active stage γp, γM (0.14, 0.2) year−1 [2]
A fraction of individuals who fail to complete treatment f variable [18]
A fraction of individuals who progress to PB strain δ 0.5 [18]
Rate of progression to active leprosy for detected
individuals who do not receive eﬀective therapy σ 0.1 year−1 [18]
The ﬁnal set of simulations (Figure 3) depicts the
dynamics of the cumulative new infections over a period
of 100 years. It suggests that if the case ﬁnding rate for
non-symptomatic individuals is less than 40%, then lep-
rosy eradication will be diﬃcult to attain. However, case
ﬁnding for any level (φ ≥ 40%) predicts that leprosy can be
eradicated from the community. Simulation conﬁrms the
analytical observation discussed earlier in this study. This
makes it clear that the case ﬁnding for non-symptomatic
carriers is necessary for leprosy eradication.
Conclusions
The number of leprosy patients registered worldwide
has fallen from a peak of 10 to 15 million to a current
total of less than 1 million. However, the transmission
of leprosy continues unabated in high-burden countries,
with the number of new leprosy cases registered each
year remaining relatively constant [20]. India is one of the
countries where at least 1, 000 new cases of leprosy were
reported during 2006 [5]. A mathematical model for the
transmission dynamics of leprosy in the context of dis-
ease relapse was set up; case ﬁndings of non-symptomatic
carriers and compliance for individuals on treatment were
formulated; mathematical properties were investigated in
order to assess the impact of disease relapse, case ﬁndings
of non-symptomatic individuals and treatment compli-
ance on the dynamics of leprosy. Qualitative analysis of
the model suggests that maintaining low levels extremely
close to zero or exactly zero percentage for leprosy relapse
cases, coupled with a high level of case ﬁnding of



































































Figure 2 Eﬀects of leprosy relapse cases and treatment compliance. Simulations of model system (11) showing the eﬀects of leprosy relapse
cases (a) and treatment compliance (b) over a period of 100 years. Parameters are ﬁxed on their baseline values from Table 1.
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Figure 3 Dynamics of the cumulative new infections. Eﬀects of
control measures on leprosy incidence (modeled by the parameter φ)
are demonstrated over a period of 80 years. The rest of the
parameters are ﬁxed on their baseline values from Table 1.
non-symptomatic leprosy carriers together with high level
of treatment compliance, may have a substantial eﬀect on
controlling a leprosy epidemic.
Methods
In this section, we introduce a mathematical model for
investigating the transmission dynamics of leprosy in
human population. We consider a population N whose
demography is regulated by a constant birth/recruitment
rate  and a natural mortality rate μ. Based on epi-
demiological status, the population is subdivided into the
following classes: susceptible (S), individuals who are not
yet infected by the disease and can be infected by Myco-
baterium leprae and join a latently infected class (E).
To account for case ﬁndings, we deﬁne φ as the rate at
which leprosy cases are detected at latent stage. Once
detected, these individuals move into the detected latent
class where they may receive chemoprophylaxis. Individ-
uals who receive eﬀective chemoprophylaxis are assumed
to recover at a rate κ , while those who do not receive
treatment become infectious at a rate σ , with a frac-
tion δ, progressing to paucibacillary leprosy (P), and the
complementary fraction (1− δ) progressing to multibacil-
lary (M). Undetected latently infected individuals who
progress to active disease do so in two diﬀerent ways.
They can develop localized, paucibacillary leprosy, with a
strong cell-mediated response, which may resolve sponta-
neously, aﬀects host survival only minimally, and is much
less transmissible [3,21]. Alternatively, they can develop
disseminatedmultibacillary disease (M), which will some-
what reduce average survival time and is more contagious.
The pathway taken (paucibacillary (PB) or multibacil-
lary (MB)) seems to be dependent not on the strain of
the organism but on the host response [3,21]. Because
borderline cases will often progress over time to either
paucibacillary or multibacillary forms, for the purposes of
simplifying our study, we have included only these two
pathways. This division of the active states of leprosy
into two discrete forms has been used in other studies
[3]. Infectious individuals are assumed to be administered
treatment and join the recovery class (R) at rates αP and
αM for those infected with paucibacillary ormultibacillary,
respectively. Thus, the total population (N) at a time t is
given by
N = S + E + ED + P + M + R.
Assuming homogeneous mixing of the population, the
susceptible acquire leprosy infection at a rate λ =
β(P+θM)
N , where β denotes the eﬀective contact rate for
leprosy transmission. Since PB is less transmissible in
comparison to MB [3], parameter θ is the enhancement
factor for assumed transmission ofMB strain compared to
PB strain. Latent individuals progress to active leprosy at
rates γP and γM for P and M, respectively. To capture the
impact of treatment compliance, we assume that a fraction
f will fail to complete treatment after 3 to 4 weeks, and
the complementary fraction (1− f ) will successfully com-
plete treatment. Some individuals in the R class relapse
back into the infective state at rates qP and qM for P and M
cases, respectively. Infectious individuals suﬀer an addi-
tional mortality at rates νP and νM, respectively, due to the
disease. The model ﬂow diagram is shown in Figure 4.
Figure 4Model ﬂow diagram.
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The deterministic compartmental model provides a
means of obtaining insight into the dynamics of lep-
rosy. As with most models for disease transmission and
control, our model is based on the simple susceptible-
infected-recovered (SIR) model [22]. The main parameter
of the SIR model is the basic reproduction number, R0.
If this parameter is below unity, then the disease dies out,
whereas if this parameter is above unity, any small intro-
duction of infected individuals in the population results
in an oscillatory approach to an endemic equilibrium.
Mathematically, there is a trivial equilibrium, known as
the disease-free equilibrium, which is globally asymptoti-
cally stable w henever R0 < 1 [14]. The aforementioned
assumptions and description above give rise to the follow-
ing system of ordinary diﬀerential equations:
S′ =  − (λ + μ)S,
E′ = λS + f αPP + f αMM − (γP + γM + φ + μ)E,
E′D = φE − (κ + σ + μ)ED ,
P′ = γPE + σδED + qPR − (αP + μ + νP)P,
M′ = γME + σ(1 − δ)ED + qMR − (αM + μ + νM)M,
R′ = κED + (1 − f )αPP + (1 − f )αMM
−(qP + qM + μ)R.
(11)
For system (11), the ﬁrst octant in the state space is pos-
itively invariant and attracting, that is, solutions that start
where all the variables are non-negative remain there.
Thus, system (11) will be analyzed in a suitable region
 ⊂ R6+, the region
 =
{
(S, E, ED, P,M,R) ∈ R6+ : N ≤ μ
}
, (12)
which is positively invariant and attracting. Existence,
uniqueness and continuation results for system (11) hold
in this region.
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